Xconomy

From Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial:

Synta Pharmaceuticals
Synta Pharmaceuticals—

Synta Pharmaceuticals is developing cancer drugs

    

Xconomy’s Most Popular

  1. The 10 Social News Apps You Need to Try
  2. 7 Lessons from TechStars’ David Cohen on Building a Startup Culture
  3. With TV App, Dijit Hopes to Ride Out the Coming Apple Revolution in TV
  4. 10 Apps & Sites That Bring Back the Joy of Reading
  5. 2012 Venture Outlook: Some Bright Spots and Some Gloom

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.